Loading...
XTSE
IVQ
Market cap132mUSD
Jul 09, Last price  
0.15USD
1D
-3.33%
1Q
-9.38%
IPO
-98.39%
Name

Invesque Inc

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.81
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.98%
Rev. gr., 5y
2.37%
Revenues
163m
-15.64%
0534,5881,503,9621,607,2471,474,8524,781,9471,715,1881,644,518873,46339,891,00063,075,000112,379,000144,689,000217,387,000210,450,000198,035,000192,829,000162,670,000
Net income
-36m
L-63.59%
00000003,367,9861,237,2724,877,00016,263,000-12,275,000-5,359,000-184,004,000-28,537,000-42,010,000-99,240,000-36,137,000
CFO
9m
+53.76%
0000000009,240,00040,814,00024,972,00016,170,00025,090,00018,680,00011,912,0006,031,0009,273,000
Dividend
Mar 30, 20200.061 USD/sh
Earnings
Aug 06, 2025

Profile

Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2022, the company owned a portfolio of 88 properties, including 60 assisted living and memory care facilities, 12 skilled nursing facilities, 10 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, which comprise the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Toronto, Canada.
URL
https://invesque.com/
IPO date
Sep 20, 2019
Employees
1,517
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
162,670
-15.64%
192,829
-2.63%
198,035
-5.90%
Cost of revenue
124,994
135,517
135,020
Unusual Expense (Income)
NOPBT
37,676
57,312
63,015
NOPBT Margin
23.16%
29.72%
31.82%
Operating Taxes
(1,605)
(312)
(1,127)
Tax Rate
NOPAT
39,281
57,624
64,142
Net income
(36,137)
-63.59%
(99,240)
136.23%
(42,010)
47.21%
Dividends
Dividend yield
Proceeds from repurchase of equity
(163)
(10,601)
BB yield
0.87%
15.22%
Debt
Debt current
292,324
279,845
444,292
Long-term debt
102,515
308,400
321,165
Deferred revenue
Other long-term liabilities
3,044
372,780
61,394
Net debt
337,091
577,500
688,801
Cash flow
Cash from operating activities
9,273
6,031
11,912
CAPEX
(4,873)
(5,814)
(6,516)
Cash from investing activities
152,213
132,051
137,485
Cash from financing activities
(154,074)
(154,916)
(141,187)
FCF
503,338
(241,012)
106,005
Balance
Cash
18,157
10,745
27,579
Long term investments
39,591
49,077
Excess cash
49,614
1,104
66,754
Stockholders' equity
90,793
134,828
223,304
Invested Capital
467,440
798,628
973,853
ROIC
6.21%
6.50%
5.92%
ROCE
7.29%
7.17%
6.06%
EV
Common stock shares outstanding
56,679
56,704
56,635
Price
0.12
-65.15%
0.33
-73.17%
1.23
-52.69%
Market cap
6,518
-65.17%
18,712
-73.14%
69,661
-52.42%
EV
343,609
682,118
844,062
EBITDA
50,932
72,896
79,531
EV/EBITDA
6.75
9.36
10.61
Interest
48,349
58,450
32,964
Interest/NOPBT
128.33%
101.99%
52.31%